Utah will let software write acne prescriptions, with a doctor checking its work for now.
The pilot, run with digital health startup Nolla Health, starts with 100 patients. A physician reviews every prescription the AI generates at the outset, according to a single report on the program. The plan calls for that oversight to shrink over time, eventually dropping to a 10 percent monthly sample of prescriptions rather than a full review. No launch date or further regulatory details beyond the pilot itself have been disclosed.
Acne is about as low-stakes as prescribing gets, which makes it a convenient place to test how much human oversight AI prescribing really needs before anyone tries this with something riskier. It also previews a familiar pattern in health tech: start with full review to build trust, then dial back the humans once the system looks like it works. That tension between speed and safety is the same one regulators have clashed with telehealth prescribers over before.
So far, the 10 percent figure is a stated goal, not a track record. The only detail available comes from one account of the pilot, and nothing has been independently verified about patient outcomes or what happens when the AI gets something wrong.